News
GELS
0.8377
+4.71%
0.0377
Weekly Report: what happened at GELS last week (1222-1226)?
Weekly Report · 12/29/2025 10:11
Weekly Report: what happened at GELS last week (1215-1219)?
Weekly Report · 12/22/2025 10:11
Gelteq Secures $1.3 Million Sales Agreement With Shenzhen Mana Health Management
Reuters · 12/16/2025 14:05
Weekly Report: what happened at GELS last week (1208-1212)?
Weekly Report · 12/15/2025 10:18
Gelteq Limited Unveils Innovative Drug Delivery Platform in Investor Summit
TipRanks · 12/09/2025 20:47
Gelteq entered into three year sales agreement with Mana Health
TipRanks · 12/09/2025 14:20
Gelteq Signs 3-Year China Distribution Deal With Mana To Expand Nutritional Product Portfolio; Expects To Derive A Minimum Revenue Of ~$1.3M During The Term Of The Agreement
Benzinga · 12/09/2025 14:16
Gelteq Signs Three-Year Sales Agreement With Shenzhen Mana Health Management for Nutritional Products in China
Reuters · 12/09/2025 14:15
GELTEQ SIGNS THREE YEAR SALES AGREEMENT WITH SHENZHEN MANA HEALTH MANAGEMENT CO. STRENGTHENING GELTEQ’S NUTRITIONAL PRODUCT EXPANSION INTO CHINA
Reuters · 12/09/2025 14:15
Weekly Report: what happened at GELS last week (1201-1205)?
Weekly Report · 12/08/2025 10:16
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 12/05/2025 21:05
Gelteq announces preclinical findings from study of gel-based platform
TipRanks · 12/05/2025 15:45
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform
Barchart · 12/05/2025 09:30
Weekly Report: what happened at GELS last week (1124-1128)?
Weekly Report · 12/01/2025 10:12
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 11/24/2025 17:05
Gelteq announces ‘positive’ preclinical results for its gel formulation
TipRanks · 11/24/2025 13:45
Gelteq Announces Preclinical Results Showing That Its Proprietary Gel-Based Oral Delivery Formulation Significantly Improves The Bioavailability Of An Antihistamine Compared To A Leading Existing Product
Benzinga · 11/24/2025 13:34
GELTEQ LTD: ANTICIPATES USING THESE RESULTS TO FURTHER PURSUE FDA APPROVAL PATHWAY FOR ANTIHISTAMINE PRODUCT
Reuters · 11/24/2025 13:31
Weekly Report: what happened at GELS last week (1117-1121)?
Weekly Report · 11/24/2025 10:17
More
Webull provides a variety of real-time GELS stock news. You can receive the latest news about Gelteq Limited through multiple platforms. This information may help you make smarter investment decisions.
About GELS
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.